CVE-2026-24222NVIDIA NeMoClaw contains a vulnerability in the sandbox environment initialization component, where a remote attacker could cause improper access control by sending prompt-injected content that cause…
Updated under an hour ago ()
Does this affect you?
It affects nvidia nemoclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
NVIDIA NeMoClaw contains a vulnerability in the sandbox environment initialization component, where a remote attacker could cause improper access control by sending prompt-injected content that causes the agent to read and exfiltrate host environment variables not properly restricted during sandbox creation. A successful exploit of this vulnerability might lead to information disclosure.
- CVSS
- 8.6 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
- Weakness (CWE)
- CWE-497
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
nvidia nemoclaw nvidia:nemoclaw | before 0.0.18 | NVD |
References
- https://nvd.nist.gov/vuln/detail/CVE-2026-24222us-government-resource
- https://nvidia.custhelp.com/app/answers/detail/a_id/5837vendor-advisory
- https://www.cve.org/CVERecord?id=CVE-2026-24222third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.